Fri, June 13, 2025
Thu, June 12, 2025
Wed, June 11, 2025
Tue, June 10, 2025
Mon, June 9, 2025
Sun, June 8, 2025
Sat, June 7, 2025
Fri, June 6, 2025
Thu, June 5, 2025
Wed, June 4, 2025
Tue, June 3, 2025
Mon, June 2, 2025
Sun, June 1, 2025
Sat, May 31, 2025
Fri, May 30, 2025
Thu, May 29, 2025
Wed, May 28, 2025
Tue, May 27, 2025
Mon, May 26, 2025
[ Mon, May 26th ] - Forbes
Is Science Slowing Down?
Sun, May 25, 2025
Sat, May 24, 2025
Fri, May 23, 2025
Thu, May 22, 2025
Wed, May 21, 2025
Tue, May 20, 2025
[ Tue, May 20th ] - 13abc
Moment of Science: Cicadas

Merck's RSV drug approval and a drug manufacturer winds down


//science-technology.news-articles.net/content/2 .. approval-and-a-drug-manufacturer-winds-down.html
Published in Science and Technology on by STAT   Print publication without navigation

And more biotech news brought to you by The Readout.

The article from STAT News dated June 10, 2025, discusses several key developments in the biotech industry. 23andMe is facing scrutiny over its data privacy practices following a data breach, prompting calls for stricter regulations. Merck and Recursion Pharmaceuticals have announced a collaboration to accelerate drug discovery using AI, aiming to bring new treatments to market more quickly. Avidity Biosciences reported positive results from a clinical trial for a new muscular dystrophy treatment, boosting its stock price. The CDC has issued new guidelines on managing respiratory viruses, emphasizing the importance of updated vaccines. Lastly, Insmed's experimental treatment for a rare lung disease showed promising results in a late-stage trial, potentially offering new hope for patients.

Read the Full STAT Article at:
[ https://www.statnews.com/2025/06/10/biotech-news-23andme-data-privacy-merck-recursion-avidity-cdc-insmed-the-readout/ ]

Publication Contributing Sources

Similar Science and Technology Publications